The FDA’s review of drug and biological products in this medication class is critical, as a brain impairment impacts between 6.5% and 7.9% of adults in the United States.
While these products are generally safe when used according to labeling, pharmacists must be familiar with available evidence in order to help patients safely self-medicate.
Prescribing low-dose aspirin for preventing secondary cardiovascular disease is well established, but its safety and efficacy in primary prevention remains open to debate.
Although there is no cure for gastroparesis, changes to the diet, along with a variety of recent and longstanding medications, can offer some relief of symptoms.